Should tumor mitotic rate and patient age, as well as tumor thickness, be used to select melanoma patients for sentinel node biopsy?
Ann Surg Oncol
.
2004 Mar;11(3):233-5.
doi: 10.1245/aso.2004.01.912.
Authors
John F Thompson
,
Helen M Shaw
PMID:
14993013
DOI:
10.1245/aso.2004.01.912
No abstract available
Publication types
Comment
Editorial
MeSH terms
Age Factors
Humans
Lymphatic Metastasis / diagnosis*
Melanoma / pathology*
Mitosis*
Neoplasm Staging*
Patient Selection*
Predictive Value of Tests
Prognosis
Sentinel Lymph Node Biopsy*
Skin Neoplasms / pathology*